The Main Contributor to SK Bioscience's Record-Breaking Subscription Amount Is in Their 60s

Subscription Hits 63 Trillion Won... Led by Those Aged 60 and Over

[Asia Economy Reporter Lee Seon-ae] NH Investment & Securities announced on the 11th that, based on an analysis of investors in the SK Bioscience IPO that closed the previous day, those in their 50s and 60s accounted for more than half, making up 60% by investment amount. In particular, investors aged 60 and above accounted for 32% by amount, and their average subscription amount was about three times the overall average, proving them to be major players.

According to last year's analysis of IPO subscriptions for SK Biopharm and Big Hit, both underwritten by NH Investment & Securities, the age distribution was as follows: △60 and above 17.81% △50s 22.17% △40s 26.94% △30s 25.12% △20s 7.47% △10 and below 0.49% for SK Biopharm, and △60 and above 14.22% △50s 22.66% △40s 27.92% △30s 25.09% △20s 9.38% △10 and below 0.72% for Big Hit.

The recent SK Bioscience IPO subscription analysis showed △60 and above 32% △50s 28.1% △40s 22.54% △30s 13.72% △20s 3.12% △10 and below 0.46%. Compared to last year's IPOs, the proportion of subscribers aged 60 and above increased significantly. According to the Asset Management Strategy Department, the rise in subscribers aged 60 and above is attributed to the recent sideways movement of the stock market, which increased interest in IPOs that offer low risk and high returns, combined with changes in the IPO allocation system.

This IPO subscription clearly reflected the effects of the equal allocation method, which started to be applied this year. Many people participated in the IPO subscription by opening accounts not only in their own names but also in their family members' names, as "the more accounts, the better." Some individuals even opened accounts at six different securities firms to subscribe. Due to many people splitting their subscriptions across multiple accounts, the number of subscription accounts reached 645,216, the highest ever. Last year, SK Biopharm had about 110,000 subscription accounts, and Big Hit had about 100,000. The average subscription amount per person was 34 million KRW, noticeably lower than SK Biopharm (120 million KRW) and Big Hit (240 million KRW), indicating that the increased number of investors was a major factor.

Meanwhile, customers who applied for 10 shares through NH Investment & Securities are expected to receive at least one share, and those who applied for about 100 million KRW (97.5 million KRW, 3,000 shares) are expected to receive at least five shares.

This content was produced with the assistance of AI translation services.